Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society
about
Treatment of Established Status EpilepticusManagement of Status Epilepticus in ChildrenNeurosteroid-sensitive δ-GABAA receptors: A role in epileptogenesis?Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus.Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data AnalysisEfficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.Standard operating procedures improve acute neurologic care in a sub-Saharan African setting.Intravenous Versus Nonintravenous Benzodiazepines for the Cessation of Seizures: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.Review article: Paediatric status epilepticus in the pre-hospital setting: An update.Nonintravenous rescue medications for pediatric status epilepticus: A cost-effectiveness analysis.Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents.Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.Treating epileptic emergencies - pharmacological advances.Nutritional and Bioenergetic Considerations in Critically Ill Patients with Acute Neurological Injury.Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.Midazolam for status epilepticus.Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.Flat Out Unnecessary: Burst Characteristics, Not Duration of Interburst Intervals, Predict Successful Anesthetic Wean in Refractory Status Epilepticus.Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus.Super-Refractory Status Epilepticus: A Therapeutic Challenge in Paediatrics.Fruitful Futility: What We Learned From a Failed Clinical Trial of Out-of-Hospital Status Epilepticus Trial.Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus.Treatment of experimental status epilepticus with synergistic drug combinations.Clinical presentation, epidemiology, neurophysiological findings, treatment and outcome of nonconvulsive status epilepticus: a 3-year prospective, hospital-based study.Providing teachers with education on epilepsy increased their willingness to handle acute seizures in children from one to 10 years of age.Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.Influence of adjunctive lacosamide in patients with seizures: a systematic review and meta-analysis.Levetiracetam Pharmacokinetics in a Critically Ill Anephric Patient on Intermittent Hemodialysis.Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat.Simultaneous triple therapy for the treatment of status epilepticus.Algorithm for the treatment of status epilepticus: a New Zealand perspective.Electroencephalographic Patterns in Neurocritical Care: Pathologic Contributors or Epiphenomena?Healthcare Utilization Characteristics for Intranasal Midazolam Versus Rectal Diazepam.Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting.Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.Management of convulsive status epilepticus in children: an adapted clinical practice guideline for pediatricians in Saudi Arabia.Timing is everything: Where status epilepticus treatment fails.Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats.
P2860
Q26749349-CE37678A-5CB0-45BC-8495-8B0FA1750F8DQ26752721-27762051-8241-4C45-981E-CB22E61F6AADQ30252495-0F1EA760-8341-418B-A318-DD5B5ADF95D2Q30252723-08122481-7573-4C7C-B1EE-A654A2F81B8AQ30396733-82ECDA9B-E7AD-4B20-B865-084081AC4B49Q33833726-EAA106FD-1D41-46E1-BD52-92627DF71FBCQ33885261-A44125EB-A3E1-4AB4-824C-C5354EF7A384Q34554104-1CA6E201-D0BC-4EEC-A4B3-AA0AE05C24D7Q38651234-27E43ABE-EE48-40A7-BB0C-AD933891A7FCQ38669567-C7975498-A769-4B00-9AC9-24FE56B8EE62Q38722907-B77B4760-D314-4355-876A-4DCC6D678798Q38880476-6F23FCF3-31F5-4499-8583-CB8233BC0E48Q38890240-EB1C28DD-A836-4703-81AC-E565B45DF016Q38968069-45D00463-934F-40C4-BC03-DCAF59BAC232Q39048335-65532541-450F-4F7A-8A87-80A28E27D132Q39109020-AA9F97CE-5527-451A-8B3D-617BD77CEA71Q39155288-C6B00673-F05F-42EF-B30E-89721353B91EQ40236390-EC178055-D320-4FA6-9F5E-19DA09636B3BQ41025564-7A73E69C-D8F9-41F6-9FC1-6F7457D41306Q41031607-3F7A3B59-32BE-47C6-86B4-6536D28CE165Q41318447-630D8EBE-46A9-483C-A9B6-B69AC5F6669EQ41874312-4B0DA944-417B-4871-A58D-BA6BF0B23137Q41969438-E4ADDB26-E806-4A4B-9774-894C3C24EC75Q46010938-DF12A46F-0002-40EE-AD6B-F3CB33B24DE4Q46171794-AB28BDB3-19EB-49BA-BE64-C10BF9B7F955Q47108940-6A9074F5-DB54-4554-8DD0-50EFD404344BQ47360141-09A84834-A834-422E-99B9-D8491F712B55Q47373267-F12C4CB1-B067-4A24-BC03-5D880EC52545Q47418044-0BFC9CE6-B6CE-433C-9270-549CEAFF569EQ47662617-78049637-FFBF-4302-BA11-7CDC76FA1125Q47705786-7D015BB7-5C56-4E22-BEB8-89720B2376E3Q47900531-D1C6042A-7163-4A3A-8020-D8E27B0E6629Q47971441-BAA84A21-5103-4A30-A16F-9D374F16E94FQ48205527-E665FF03-441D-4CDB-94A8-B2D59A350624Q49892581-567DAD5A-0C66-4282-BF0A-A08445102946Q50090270-3B8FFC05-1970-4E8D-A9A5-E3CA9AED0F92Q50092845-0AD92748-5553-443B-9A00-EA3F8A2E70E8Q50318087-77F52D71-50C8-43C2-AABE-83FE313BFE1EQ50543732-E6ACF8E1-D05B-43A7-B797-152FC884F36BQ53404630-3A22A720-CB72-427F-A9C0-CBC613C58ADB
P2860
Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@ast
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@en
type
label
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@ast
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@en
prefLabel
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@ast
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@en
P2093
P2860
P1433
P1476
Evidence-Based Guideline: Trea ...... the American Epilepsy Society
@en
P2093
Andy Jagoda
Brian Alldredge
Daniel Lowenstein
David Gloss
David M Treiman
Edward Sloan
Jacquelyn Bainbridge
James Riviello
John Pellock
Lisa Garrity
P2860
P356
10.5698/1535-7597-16.1.48
P407
P577
2016-01-01T00:00:00Z